Order Article Reprints

Belmonte B, Cancila V, Gulino A, Navari M, Arancio W, Macor P, Balduit A, Capolla S, Morello G, Vacca D, et al. Constitutive PSGL-1 Correlates with CD30 and TCR Pathways and Represents a Potential Target for Immunotherapy in Anaplastic Large T-Cell Lymphoma. Cancers. 2021; 13(12):2958. https://doi.org/10.3390/cancers13122958

Belmonte, Beatrice, Valeria Cancila, Alessandro Gulino, Mohsen Navari, Walter Arancio, Paolo Macor, Andrea Balduit, Sara Capolla, Gaia Morello, Davide Vacca, and et al. 2021. "Constitutive PSGL-1 Correlates with CD30 and TCR Pathways and Represents a Potential Target for Immunotherapy in Anaplastic Large T-Cell Lymphoma" Cancers 13, no. 12: 2958. https://doi.org/10.3390/cancers13122958

Belmonte, B., Cancila, V., Gulino, A., Navari, M., Arancio, W., Macor, P., Balduit, A., Capolla, S., Morello, G., Vacca, D., Ferrara, I., Bertolazzi, G., Balistreri, C. R., Amico, P., Ferrante, F., Maiorana, A., Salviato, T., Piccaluga, P. P., & Mangogna, A. (2021). Constitutive PSGL-1 Correlates with CD30 and TCR Pathways and Represents a Potential Target for Immunotherapy in Anaplastic Large T-Cell Lymphoma. Cancers, 13(12), 2958. https://doi.org/10.3390/cancers13122958